APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-based Hemostatic Powder

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bio-based Hemostatic Powder Market Outlook and Growth Opportunities 2026

27 December 2025193 pages

Choose your research edition.

Industry ResearchBio-based Hemostatic Powder Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-based Hemostatic Powder Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Bio-based Hemostatic Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-based Hemostatic Powder Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-based Hemostatic Powder Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bio-based Hemostatic Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bio-based Hemostatic Powder market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bio-based Hemostatic Powder market include BD, Lanhine Medical, Yancheng Yankang Medical Equipment, Success Bio-Tech, Johnson & Johnson, Haiyuan Hairun, Beijing Aitekang Medical Technology, Baxter and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bio-based Hemostatic Powder market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bio-based Hemostatic Powder and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bio-based Hemostatic Powder sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bio-based Hemostatic Powder market size, projected growth trends, production technologies, key applications, and end-use industries.

Bio-based Hemostatic Powder Segment by Company

BD

Lanhine Medical

Yancheng Yankang Medical Equipment

Success Bio-Tech

Johnson & Johnson

Haiyuan Hairun

Beijing Aitekang Medical Technology

Baxter

Medtronic

MedTrade Products

Hemostasis

BioCer Entwicklungs-GmbH

Bio-based Hemostatic Powder Segment by Type

Oxidized Cellulose

Polysaccharides

Other

Bio-based Hemostatic Powder Segment by Application

Surgery

First Aid

Bio-based Hemostatic Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bio-based Hemostatic Powder status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bio-based Hemostatic Powder market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bio-based Hemostatic Powder significant trends, drivers, influence factors in global and regions.

6. To analyze Bio-based Hemostatic Powder competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Hemostatic Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-based Hemostatic Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Hemostatic Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bio-based Hemostatic Powder market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bio-based Hemostatic Powder industry.

Chapter 3: Detailed analysis of Bio-based Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bio-based Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bio-based Hemostatic Powder in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bio-based Hemostatic Powder Industry Trends Table 2. Bio-based Hemostatic Powder Industry Drivers Table 3. Bio-based Hemostatic Powder Industry Opportunities and Challenges Table 4. Bio-based Hemostatic Powder Industry Restraints Table 5. Global Bio-based Hemostatic Powder Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bio-based Hemostatic Powder Revenue Share by Company (2021-2026) Table 7. Global Bio-based Hemostatic Powder Sales Volume by Company (Units) & (2021-2026) Table 8. Global Bio-based Hemostatic Powder Sales Volume Share by Company (2021-2026) Table 9. Global Bio-based Hemostatic Powder Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bio-based Hemostatic Powder Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bio-based Hemostatic Powder Key Company Manufacturing Base & Headquarters Table 12. Global Bio-based Hemostatic Powder Company, Product Type & Application Table 13. Global Bio-based Hemostatic Powder Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bio-based Hemostatic Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oxidized Cellulose Table 18. Significant Companies of Polysaccharides Table 19. Significant Companies of Other Table 20. Global Bio-based Hemostatic Powder Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Bio-based Hemostatic Powder Sales Volume by Type (2021-2026) & (Units) Table 22. Global Bio-based Hemostatic Powder Sales Volume by Type (2027-2032) & (Units) Table 23. Global Bio-based Hemostatic Powder Sales Volume Share by Type (2021-2026) Table 24. Global Bio-based Hemostatic Powder Sales Volume Share by Type (2027-2032) Table 25. Global Bio-based Hemostatic Powder Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bio-based Hemostatic Powder Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bio-based Hemostatic Powder Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bio-based Hemostatic Powder Sales Value Share by Type (2021-2026) Table 29. Global Bio-based Hemostatic Powder Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Surgery Table 31. Significant Companies of First Aid Table 32. Global Bio-based Hemostatic Powder Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Bio-based Hemostatic Powder Sales Volume by Application (2021-2026) & (Units) Table 34. Global Bio-based Hemostatic Powder Sales Volume by Application (2027-2032) & (Units) Table 35. Global Bio-based Hemostatic Powder Sales Volume Share by Application (2021-2026) Table 36. Global Bio-based Hemostatic Powder Sales Volume Share by Application (2027-2032) Table 37. Global Bio-based Hemostatic Powder Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bio-based Hemostatic Powder Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bio-based Hemostatic Powder Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bio-based Hemostatic Powder Sales Value Share by Application (2021-2026) Table 41. Global Bio-based Hemostatic Powder Sales Value Share by Application (2027-2032) Table 42. Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Bio-based Hemostatic Powder Sales by Region (2021-2026) & (Units) Table 44. Global Bio-based Hemostatic Powder Sales Market Share by Region (2021-2026) Table 45. Global Bio-based Hemostatic Powder Sales by Region (2027-2032) & (Units) Table 46. Global Bio-based Hemostatic Powder Sales Market Share by Region (2027-2032) Table 47. Global Bio-based Hemostatic Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bio-based Hemostatic Powder Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bio-based Hemostatic Powder Sales Value Share by Region (2021-2026) Table 50. Global Bio-based Hemostatic Powder Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bio-based Hemostatic Powder Sales Value Share by Region (2027-2032) Table 52. Global Bio-based Hemostatic Powder Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bio-based Hemostatic Powder Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Bio-based Hemostatic Powder Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 57. Global Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 58. Global Bio-based Hemostatic Powder Sales by Country (2027-2032) & (Units) Table 59. Global Bio-based Hemostatic Powder Sales Market Share by Country (2027-2032) Table 60. Global Bio-based Hemostatic Powder Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bio-based Hemostatic Powder Sales Value Market Share by Country (2021-2026) Table 62. Global Bio-based Hemostatic Powder Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bio-based Hemostatic Powder Sales Value Market Share by Country (2027-2032) Table 64. BD Company Information Table 65. BD Business Overview Table 66. BD Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BD Bio-based Hemostatic Powder Product Portfolio Table 68. BD Recent Development Table 69. Lanhine Medical Company Information Table 70. Lanhine Medical Business Overview Table 71. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Lanhine Medical Bio-based Hemostatic Powder Product Portfolio Table 73. Lanhine Medical Recent Development Table 74. Yancheng Yankang Medical Equipment Company Information Table 75. Yancheng Yankang Medical Equipment Business Overview Table 76. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio Table 78. Yancheng Yankang Medical Equipment Recent Development Table 79. Success Bio-Tech Company Information Table 80. Success Bio-Tech Business Overview Table 81. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio Table 83. Success Bio-Tech Recent Development Table 84. Johnson & Johnson Company Information Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio Table 88. Johnson & Johnson Recent Development Table 89. Haiyuan Hairun Company Information Table 90. Haiyuan Hairun Business Overview Table 91. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio Table 93. Haiyuan Hairun Recent Development Table 94. Beijing Aitekang Medical Technology Company Information Table 95. Beijing Aitekang Medical Technology Business Overview Table 96. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio Table 98. Beijing Aitekang Medical Technology Recent Development Table 99. Baxter Company Information Table 100. Baxter Business Overview Table 101. Baxter Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Baxter Bio-based Hemostatic Powder Product Portfolio Table 103. Baxter Recent Development Table 104. Medtronic Company Information Table 105. Medtronic Business Overview Table 106. Medtronic Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Medtronic Bio-based Hemostatic Powder Product Portfolio Table 108. Medtronic Recent Development Table 109. MedTrade Products Company Information Table 110. MedTrade Products Business Overview Table 111. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. MedTrade Products Bio-based Hemostatic Powder Product Portfolio Table 113. MedTrade Products Recent Development Table 114. Hemostasis Company Information Table 115. Hemostasis Business Overview Table 116. Hemostasis Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hemostasis Bio-based Hemostatic Powder Product Portfolio Table 118. Hemostasis Recent Development Table 119. BioCer Entwicklungs-GmbH Company Information Table 120. BioCer Entwicklungs-GmbH Business Overview Table 121. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio Table 123. BioCer Entwicklungs-GmbH Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Bio-based Hemostatic Powder Distributors List Table 127. Bio-based Hemostatic Powder Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Bio-based Hemostatic Powder Product Image Figure 2. Global Bio-based Hemostatic Powder Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bio-based Hemostatic Powder Sales (2021-2032) & (Units) Figure 5. Global Bio-based Hemostatic Powder Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bio-based Hemostatic Powder Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oxidized Cellulose Image Figure 10. Polysaccharides Image Figure 11. Other Image Figure 12. Global Bio-based Hemostatic Powder Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Bio-based Hemostatic Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bio-based Hemostatic Powder Sales Volume Share by Type (2021-2032) Figure 15. Global Bio-based Hemostatic Powder Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bio-based Hemostatic Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bio-based Hemostatic Powder Sales Value Share by Type (2021-2032) Figure 18. Surgery Image Figure 19. First Aid Image Figure 20. Global Bio-based Hemostatic Powder Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Bio-based Hemostatic Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bio-based Hemostatic Powder Sales Volume Share by Application (2021-2032) Figure 23. Global Bio-based Hemostatic Powder Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bio-based Hemostatic Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bio-based Hemostatic Powder Sales Value Share by Application (2021-2032) Figure 26. Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Bio-based Hemostatic Powder Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bio-based Hemostatic Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bio-based Hemostatic Powder Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bio-based Hemostatic Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bio-based Hemostatic Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bio-based Hemostatic Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bio-based Hemostatic Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bio-based Hemostatic Powder Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bio-based Hemostatic Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bio-based Hemostatic Powder Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bio-based Hemostatic Powder Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oxidized Cellulose
  • Polysaccharides
  • Other
Applications
  • Surgery
  • First Aid
Companies covered
  • BD
  • Lanhine Medical
  • Yancheng Yankang Medical Equipment
  • Success Bio-Tech
  • Johnson & Johnson
  • Haiyuan Hairun
  • Beijing Aitekang Medical Technology
  • Baxter
  • Medtronic
  • MedTrade Products
  • Hemostasis
  • BioCer Entwicklungs-GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio-based Hemostatic Powder Sales Value (2021-2032)
  4. 1.2.2 Global Bio-based Hemostatic Powder Sales Volume (2021-2032)
  5. 1.2.3 Global Bio-based Hemostatic Powder Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bio-based Hemostatic Powder Market Dynamics
  1. 2.1 Bio-based Hemostatic Powder Industry Trends
  2. 2.2 Bio-based Hemostatic Powder Industry Drivers
  3. 2.3 Bio-based Hemostatic Powder Industry Opportunities and Challenges
  4. 2.4 Bio-based Hemostatic Powder Industry Restraints
3 Bio-based Hemostatic Powder Market by Company
  1. 3.1 Global Bio-based Hemostatic Powder Company Revenue Ranking in 2025
  2. 3.2 Global Bio-based Hemostatic Powder Revenue by Company (2021-2026)
  3. 3.3 Global Bio-based Hemostatic Powder Sales Volume by Company (2021-2026)
  4. 3.4 Global Bio-based Hemostatic Powder Average Price by Company (2021-2026)
  5. 3.5 Global Bio-based Hemostatic Powder Company Ranking (2024-2026)
  6. 3.6 Global Bio-based Hemostatic Powder Company Manufacturing Base and Headquarters
  7. 3.7 Global Bio-based Hemostatic Powder Company Product Type and Application
  8. 3.8 Global Bio-based Hemostatic Powder Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bio-based Hemostatic Powder Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bio-based Hemostatic Powder Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bio-based Hemostatic Powder Market by Type
  1. 4.1 Bio-based Hemostatic Powder Type Introduction
  2. 4.1.1 Oxidized Cellulose
  3. 4.1.2 Polysaccharides
  4. 4.1.3 Other
  5. 4.2 Global Bio-based Hemostatic Powder Sales Volume by Type
  6. 4.2.1 Global Bio-based Hemostatic Powder Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bio-based Hemostatic Powder Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bio-based Hemostatic Powder Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bio-based Hemostatic Powder Sales Value by Type
  10. 4.3.1 Global Bio-based Hemostatic Powder Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bio-based Hemostatic Powder Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bio-based Hemostatic Powder Sales Value Share by Type (2021-2032)
5 Bio-based Hemostatic Powder Market by Application
  1. 5.1 Bio-based Hemostatic Powder Application Introduction
  2. 5.1.1 Surgery
  3. 5.1.2 First Aid
  4. 5.2 Global Bio-based Hemostatic Powder Sales Volume by Application
  5. 5.2.1 Global Bio-based Hemostatic Powder Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bio-based Hemostatic Powder Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Bio-based Hemostatic Powder Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Bio-based Hemostatic Powder Sales Value by Application
  9. 5.3.1 Global Bio-based Hemostatic Powder Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bio-based Hemostatic Powder Sales Value by Application (2021-2032)
  11. 5.3.3 Global Bio-based Hemostatic Powder Sales Value Share by Application (2021-2032)
6 Bio-based Hemostatic Powder Regional Sales and Value Analysis
  1. 6.1 Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bio-based Hemostatic Powder Sales by Region (2021-2032)
  3. 6.2.1 Global Bio-based Hemostatic Powder Sales by Region: 2021-2026
  4. 6.2.2 Global Bio-based Hemostatic Powder Sales by Region (2027-2032)
  5. 6.3 Global Bio-based Hemostatic Powder Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bio-based Hemostatic Powder Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bio-based Hemostatic Powder Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bio-based Hemostatic Powder Sales Value by Region (2027-2032)
  9. 6.5 Global Bio-based Hemostatic Powder Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bio-based Hemostatic Powder Sales Value (2021-2032)
  12. 6.6.2 North America Bio-based Hemostatic Powder Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bio-based Hemostatic Powder Sales Value (2021-2032)
  15. 6.7.2 Europe Bio-based Hemostatic Powder Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bio-based Hemostatic Powder Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bio-based Hemostatic Powder Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bio-based Hemostatic Powder Sales Value (2021-2032)
  21. 6.9.2 South America Bio-based Hemostatic Powder Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bio-based Hemostatic Powder Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bio-based Hemostatic Powder Sales Value Share by Country, 2025 VS 2032
7 Bio-based Hemostatic Powder Country-level Sales and Value Analysis
  1. 7.1 Global Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bio-based Hemostatic Powder Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bio-based Hemostatic Powder Sales by Country (2021-2032)
  4. 7.3.1 Global Bio-based Hemostatic Powder Sales by Country (2021-2026)
  5. 7.3.2 Global Bio-based Hemostatic Powder Sales by Country (2027-2032)
  6. 7.4 Global Bio-based Hemostatic Powder Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bio-based Hemostatic Powder Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bio-based Hemostatic Powder Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bio-based Hemostatic Powder Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bio-based Hemostatic Powder Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bio-based Hemostatic Powder Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BD Bio-based Hemostatic Powder Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Lanhine Medical
  8. 8.2.1 Lanhine Medical Company Information
  9. 8.2.2 Lanhine Medical Business Overview
  10. 8.2.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio
  12. 8.2.5 Lanhine Medical Recent Developments
  13. 8.3 Yancheng Yankang Medical Equipment
  14. 8.3.1 Yancheng Yankang Medical Equipment Company Information
  15. 8.3.2 Yancheng Yankang Medical Equipment Business Overview
  16. 8.3.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio
  18. 8.3.5 Yancheng Yankang Medical Equipment Recent Developments
  19. 8.4 Success Bio-Tech
  20. 8.4.1 Success Bio-Tech Company Information
  21. 8.4.2 Success Bio-Tech Business Overview
  22. 8.4.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio
  24. 8.4.5 Success Bio-Tech Recent Developments
  25. 8.5 Johnson & Johnson
  26. 8.5.1 Johnson & Johnson Company Information
  27. 8.5.2 Johnson & Johnson Business Overview
  28. 8.5.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio
  30. 8.5.5 Johnson & Johnson Recent Developments
  31. 8.6 Haiyuan Hairun
  32. 8.6.1 Haiyuan Hairun Company Information
  33. 8.6.2 Haiyuan Hairun Business Overview
  34. 8.6.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio
  36. 8.6.5 Haiyuan Hairun Recent Developments
  37. 8.7 Beijing Aitekang Medical Technology
  38. 8.7.1 Beijing Aitekang Medical Technology Company Information
  39. 8.7.2 Beijing Aitekang Medical Technology Business Overview
  40. 8.7.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio
  42. 8.7.5 Beijing Aitekang Medical Technology Recent Developments
  43. 8.8 Baxter
  44. 8.8.1 Baxter Company Information
  45. 8.8.2 Baxter Business Overview
  46. 8.8.3 Baxter Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Baxter Bio-based Hemostatic Powder Product Portfolio
  48. 8.8.5 Baxter Recent Developments
  49. 8.9 Medtronic
  50. 8.9.1 Medtronic Company Information
  51. 8.9.2 Medtronic Business Overview
  52. 8.9.3 Medtronic Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medtronic Bio-based Hemostatic Powder Product Portfolio
  54. 8.9.5 Medtronic Recent Developments
  55. 8.10 MedTrade Products
  56. 8.10.1 MedTrade Products Company Information
  57. 8.10.2 MedTrade Products Business Overview
  58. 8.10.3 MedTrade Products Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio
  60. 8.10.5 MedTrade Products Recent Developments
  61. 8.11 Hemostasis
  62. 8.11.1 Hemostasis Company Information
  63. 8.11.2 Hemostasis Business Overview
  64. 8.11.3 Hemostasis Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio
  66. 8.11.5 Hemostasis Recent Developments
  67. 8.12 BioCer Entwicklungs-GmbH
  68. 8.12.1 BioCer Entwicklungs-GmbH Company Information
  69. 8.12.2 BioCer Entwicklungs-GmbH Business Overview
  70. 8.12.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio
  72. 8.12.5 BioCer Entwicklungs-GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bio-based Hemostatic Powder Value Chain Analysis
  2. 9.1.1 Bio-based Hemostatic Powder Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bio-based Hemostatic Powder Sales Mode & Process
  6. 9.2 Bio-based Hemostatic Powder Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bio-based Hemostatic Powder Distributors
  9. 9.2.3 Bio-based Hemostatic Powder Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst